A case of unknown origin inguinal lymph node squamous cell carcinoma, accompanied with carcinoma in situ of cervix

다국어 초록 (Multilingual Abstract)

Metastatic Cancer of Unknown Primary Site (CUP) accounts for approximately 3-5% of all malignant neoplasms. CUP represents a heterogeneous group of metastatic tumors for which no primary site can be detected following a thorough medical history, careful clinical examination and extensive diagnostic work-up. Several authors had reported the poor prognosis of this malignancy, because there is no consensus on diagnostic guideline and optimal therapy. Historically chemotherapy has been the cornerstone of treatment for patients with CUP. We experienced a case of unknown origin inguinal lymph node squamous cell carcinoma, accompanied with carcinoma in situ of cervix. We report this case with a brief review of the literatures.

참고문헌 (Reference)

1 Hillen HF, "Unknown primary tumours" 76 : 690-693, 2000

2 ost P, "Unknown primary tumors as a unique clinical and biologic entity: A hypotheis" 41 : 139-141, 1989

3 Burbos N, "Unknown primary site of serous papillary adenocarcinoma involving inguinal, iliac and obturator lymph nodes co-existing with endometrial adenocarcinoma" 27 : 542-543, 2007

4 Greco FA, "The evolving role of paclitaxel for patients with carcinoma of unknown primary site" 26 (26): 129-133, 1999

5 Pavlidis N, "Subsets of tumors responsive to cisplatin or carboplatin combination in patients with carcinoma of unknown primary site" 3 : 631-634, 1992

6 Greco FA, "Poorly differentiated carcinoma or adenocarcinoma of unknown primary site: Long-term results with cisplatin-based chemotherapy" 21 (21): 77-82, 1994

7 Guarischi A, "Metastatic inguinal nodes from an unknown primary neoplasm. A review of 56 cases" 59 : 572-577, 1987

8 Holmes FF, "Metastatic cancer of unknown primary site" 26 : 816-820, 1970

9 Casciato DA, "Metastases on unknown origin. In: Cancer Treatment. 3rd ed" WB Saunders 798-814, 1990

10 Petrovićć D, "Metastases of unknown origin-principles of diagnosis and treatment" 60 : 29-36, 2007

11 Hainsworth JD, "Management of patients with cancer of unknown primary site" 14 : 563-574, 2000

12 Zaren HA, "Inguinal node metastases" 41 : 919-923, 1978

13 Pavlidis N, "Evaluation of six tumor markers in patients with carcinoma of unknown primary" 22 : 162-167, 1994

14 Pavlidis N, "Diagnostic and therapeutic management of cancer of an unknown primary" 39 : 1990-2005, 2003

15 Greco FA, "Carcinoma of unknown primary site: Phase II trials with docetaxel plus cisplatin or carboplatin" 11 : 211-215, 2000

16 Greco FA, "Carcinoma of unknown primary site: Long term follow-up after treatment with paclitaxel, carboplatin and etoposide" 89 : 2655-2660, 2000

17 Blaszyk H, "Cancer of unknown primary: clinicopathologic correlations" 111 : 1089-1094, 2003

18 Greco FA, "Cancer of unknown primary site. In: Cancer: Principles and Practice of Oncology. 4th ed" J.B. Lippincott Co 2423-2443, 1997

19 Abbruzzese JL, "Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin" 13 : 2094-2103, 1995

20 Abbruzzese JL, "Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin" 13 : 2094-2103, 1995